Enrichment analysis of genes dysregulated following Rosiglitazone effect on prdm16-deficient inguinal white adipose tissue treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013870
TitleEnrichment analysis of genes dysregulated following Rosiglitazone effect on prdm16-deficient inguinal white adipose tissue treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Rosiglitazone effect on prdm16-deficient inguinal white adipose tissue treated cells and untreated control cells in the stromal-vascular cells cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088691
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorjustinenoel
CREEDS IDdrug:3099
Cell Typestromal-vascular cells
Drug NameRosiglitazone effect on prdm16-deficient inguinal white adipose tissue
Organismmouse
PubChem CID77999
SMILES IDCN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
Characteristic Direction parameters
Control SamplesGSM860622, GSM860623
Perturbed SamplesGSM860626, GSM860627
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE35011
Gene Expression Omnibus
Rosiglitazone effect on PRDM16-deficient inguinal white adipose tissue: stromal-vascular cells
28
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.